Foreign financial stocks have seen significant gains in 2025, with some showing more room to run. Stocks with the most bullish profiles are listed here, highlighting those that have booked substantial gains this year and are well-positioned to maintain momentum.
Foreign financial stocks have seen significant gains in 2025, with some showing more room to run. Stocks with the most bullish profiles are listed here, highlighting those that have booked substantial gains this year and are well-positioned to maintain momentum.
Alibaba Group Holding Ltd. (BABA) has rebounded strongly, up 30% year-to-date. The e-commerce giant, often referred to as the "Amazon.com of Asia," has benefited from the acceleration of AI in its e-commerce operations and its unique position in the Chinese market, which is less impacted by trade wars. Despite recent regulatory challenges, Alibaba remains a favorite among investors due to its steady revenue growth expectations [1].
ASML Holding NV (ASML) has seen a 15% gain since the start of the year. This Dutch company manufactures advanced semiconductor equipment systems, making it crucial to global supply chains. ASML's revenue growth is expected to be around 13% this year and almost 10% in fiscal year 2026, making it a strong performer in the tech sector [1].
Celestica Inc. (CLS) has surged more than 60% since January, driven by the demand for electronic components and semiconductors. The Canadian company has benefited from the fallout of U.S. protectionist trade policies, which have reinforced its role in the supply chain [1].
Elbit Systems Ltd. (ESLT) has seen consistent double-digit revenue growth and strong profitability, contributing to a 60% gain in 2025. As a defense and homeland security company based in Israel, ESLT has benefited from the persistent tensions in the Middle East [1].
MercadoLibre Inc. (MELI) has surged 45% since January, driven by its strong user base and growing product offerings. The Latin American e-commerce leader has seen nearly 67 million unique buyers and over 64 million monthly active users in its commerce business [1].
Novo Nordisk A/S (NVO) has seen a 15% revenue growth expected for both fiscal years 2025 and 2026. The Danish pharmaceutical company specializes in diabetes and obesity care, with blockbuster treatments like Wegovy driving its success [1].
Spotify Technology SA (SPOT) has seen a 60% gain since January, driven by cost-cutting and restructuring efforts. The music and podcast streamer has seen 12% subscriber growth and 15% revenue growth in the first quarter of 2025, positioning it well for continued growth [1].
These international growth stocks have shown strong performance in 2025 and are well-positioned to continue their momentum. Investors seeking exposure to global growth should consider these stocks, which offer diversification and the potential for strong returns.
References:
[1] https://money.usnews.com/investing/articles/best-international-growth-stocks-to-buy-now
[2] https://www.cnbc.com/2025/07/09/global-stock-markets-best-and-worst-performers-in-2025-so-far.html
Comments
No comments yet